FOR IMMEDIATE RELEASE
SALT LAKE CITY, UTAH (February 4, 2025) – Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced the addition of Quadraflex® AREX to its medical-grade polyurethane material offerings.
This new Quadraflex® product broadens Biomerics’ wide range of materials with chemistries and durometers for solution processing, complex extrusions, medical balloons and injection molding processes. Quadraflex® AREX, an aromatic polyether thermoplastic polyurethane, was developed in a key range of hardnesses to address the need for a high-quality medical-grade polymer that is available in high volumes and has a short lead time, competitive pricing and excellent technical support. This new product is ISO 10993 and USP Class VI compliant and is free of animal-derived materials. The continued development of Biomerics’ engineering Materials Center of Excellence keeps them at the forefront of contract design and manufacturing excellence in the polyurethane space.
Biomerics customizes polyurethanes and other engineered polymers for medical device applications, adding the desired colorants, radiopacifiers and other additives. Their customized polymer solutions meet the biocompatibility, biostability, durability and processing stability requirements for the most demanding catheters and interventional devices. Biomerics’ polymer chemists regularly develop and validate medical-grade polymers for a full range of highly specialized, complex interventional medical devices and components.
Kevin Grussing, President of Biomerics’ Plastics Division, says, “Our Quadra™ family of medical polyurethanes is a valuable element of our performance materials manufacturing capabilities. Investing in innovative, customizable solutions like this that are readily available at high volumes enables us to better serve our global customers. The Quadraflex® AREX product addition reflects our ongoing commitment to providing best-in-class polyurethane solutions that meet the evolving design and manufacturing needs of our partners.”
About Biomerics:
Founded in 1994, Biomerics is the leading vertically integrated medical device contract manufacturer serving the interventional device market. Trusted as a vertically integrated partner with extensive engineering expertise and solutions, Biomerics supplies 20 of the top 30 medical device OEMs globally. Biomerics provides engineering design and development, manufacturing technology transfer, and contract manufacturing services — including sterilization and packaging — for medical device components, subassemblies and finished medical devices. Through nine locations in the United States, two locations in Costa Rica, one in the Dominican Republic and one in Ireland, Biomerics meets customers’ immediate and long-term strategic needs. With comprehensive engineering Centers of Excellence, Biomerics is a leader in performance materials, interventional medical plastics, complex extrusions, micromachining of metals and polymers, laser processing, balloons and balloon catheters, advanced catheters and steerables, guidewires, image guided intervention, micro-overmolding, micro precision stamping, metal injection molding (MIM), and complex microassembly and finished device assembly. In addition to operating under a certified ISO 13485:2016 quality system, Biomerics is FDA registered and compliant with FDA 21 CFR Part 820.
Contact
Daniel Craven
Director, Marketing & Communications
Biomerics, LLC
Phone: +1 888–774-7787
Email: marketing@biomerics.com